Notable Labs Current Ratio 2013-2024 | NTBLQ
Notable Labs current ratio from 2013 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Notable Labs Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-06-30 |
$0.01B |
$0.00B |
2.78 |
| 2024-03-31 |
$0.01B |
$0.00B |
4.66 |
| 2023-12-31 |
$0.02B |
$0.00B |
5.65 |
| 2023-09-30 |
$0.02B |
$0.00B |
8.05 |
| 2023-06-30 |
$0.03B |
$0.01B |
4.63 |
| 2023-03-31 |
$0.03B |
$0.01B |
3.48 |
| 2022-12-31 |
$0.00B |
$0.00B |
1.48 |
| 2022-09-30 |
$0.03B |
$0.01B |
2.82 |
| 2022-06-30 |
$0.04B |
$0.01B |
4.05 |
| 2022-03-31 |
$0.05B |
$0.01B |
4.21 |
| 2021-12-31 |
$0.06B |
$0.01B |
5.53 |
| 2021-09-30 |
$0.05B |
$0.01B |
6.75 |
| 2021-06-30 |
$0.06B |
$0.01B |
6.74 |
| 2021-03-31 |
$0.04B |
$0.01B |
5.55 |
| 2020-12-31 |
$0.03B |
$0.01B |
4.29 |
| 2020-09-30 |
$0.04B |
$0.01B |
5.16 |
| 2020-06-30 |
$0.04B |
$0.01B |
6.41 |
| 2020-03-31 |
$0.03B |
$0.01B |
4.11 |
| 2019-12-31 |
$0.04B |
$0.01B |
4.36 |
| 2019-09-30 |
$0.04B |
$0.01B |
5.49 |
| 2019-06-30 |
$0.05B |
$0.01B |
6.45 |
| 2019-03-31 |
$0.05B |
$0.01B |
8.35 |
| 2018-12-31 |
$0.05B |
$0.01B |
10.83 |
| 2018-09-30 |
$0.06B |
$0.01B |
11.46 |
| 2018-06-30 |
$0.06B |
$0.01B |
10.44 |
| 2018-03-31 |
$0.05B |
$0.01B |
6.59 |
| 2017-12-31 |
$0.06B |
$0.01B |
7.72 |
| 2017-09-30 |
$0.03B |
$0.01B |
5.87 |
| 2017-06-30 |
$0.04B |
$0.01B |
6.48 |
| 2017-03-31 |
$0.04B |
$0.01B |
9.22 |
| 2016-12-31 |
$0.05B |
$0.01B |
9.73 |
| 2016-09-30 |
$0.05B |
$0.00B |
13.12 |
| 2016-06-30 |
$0.05B |
$0.00B |
12.74 |
| 2016-03-31 |
$0.03B |
$0.00B |
8.58 |
| 2015-12-31 |
$0.04B |
$0.00B |
9.28 |
| 2015-09-30 |
$0.03B |
$0.01B |
5.57 |
| 2015-06-30 |
$0.03B |
$0.00B |
9.68 |
| 2015-03-31 |
$0.04B |
$0.00B |
11.96 |
| 2014-12-31 |
$0.04B |
$0.00B |
12.88 |
| 2014-09-30 |
$0.01B |
$0.01B |
1.50 |
| 2014-06-30 |
$0.00B |
|
0.00 |
| 2014-03-31 |
$0.00B |
|
0.00 |
| 2013-12-31 |
$0.01B |
$0.00B |
2.68 |
| 2013-09-30 |
$0.00B |
|
0.00 |
| 2012-12-31 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|
